Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1932-1948. doi: 10.1002/jcsm.13321. Epub 2023 Sep 6.
J Cachexia Sarcopenia Muscle. 2023.
PMID: 37671529
Free PMC article.
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS; Cancer Cachexia Endpoints Working Group.
Vagnildhaug OM, et al.
J Cachexia Sarcopenia Muscle. 2024 Apr;15(2):513-535. doi: 10.1002/jcsm.13434. Epub 2024 Feb 11.
J Cachexia Sarcopenia Muscle. 2024.
PMID: 38343065
Free PMC article.
Review.
Item in Clipboard
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ, Jakobsen G, Arends J, Balstad T, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM, Laird BJA; Cancer Cachexia Endpoints Working Group.
Hjermstad MJ, et al.
J Cachexia Sarcopenia Muscle. 2024 Mar 29. doi: 10.1002/jcsm.13453. Online ahead of print.
J Cachexia Sarcopenia Muscle. 2024.
PMID: 38553255
Free article.
Review.
Item in Clipboard
[Misleading about diet in a new national guideline for the prevention of cardiovascular disease].
Narverud I, Christensen JJ, Ottestad IO, Ulven SM, Holven KB.
Narverud I, et al. Among authors: ottestad io.
Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0834. Print 2017 Oct 31.
Tidsskr Nor Laegeforen. 2017.
PMID: 29094560
Free article.
Norwegian.
No abstract available.
Item in Clipboard
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux.
Ottestad IO, Halvorsen B, Balstad TR, Otterdal K, Borge GI, Brosstad F, Myhre AM, Ose L, Nenseter MS, Holven KB.
Ottestad IO, et al.
J Nutr. 2006 Apr;136(4):877-81. doi: 10.1093/jn/136.4.877.
J Nutr. 2006.
PMID: 16549444
Free article.
Item in Clipboard
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.
Balstad TR, Holven KB, Ottestad IO, Otterdal K, Halvorsen B, Myhre AM, Ose L, Nenseter MS.
Balstad TR, et al. Among authors: ottestad io.
Clin Chim Acta. 2005 Sep;359(1-2):171-8. doi: 10.1016/j.cccn.2005.03.050.
Clin Chim Acta. 2005.
PMID: 15936009
Item in Clipboard
Cite
Cite